
    
      Treatment is titrated to optimal dose (that at which investigator and subject felt that motor
      and non motor impairment are adequately controlled), starting at 2 mg/24 hr and increasing
      with weekly increments of 2 mg/24 hr up to a maximum of 8 mg/24 hr. The dose is maintained at
      the optimal or maximal dose for a 8-week period (maintenance period) .
    
  